Literature DB >> 17913656

Insights into JAK2-V617F mutation in CML.

Guntram Büsche, Kais Hussein, Oliver Bock, Hans Kreipe.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17913656     DOI： 10.1016/S1470-2045(07)70294-2

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  4 in total

1.  Simultaneous detection of JAK2 V617F mutation and Bcr-Abl translocation in a patient with chronic myelogenous leukemia.

Authors:  Monika Ribeiro Mello de Conchon; Juliana Lima Costa; Mafalda Megumi Yoshinaga Novaes; Pedro Enrique Dorlhiac-Llacer; Dalton de Alencar Fischer Chamone; Israel Bendit
Journal:  Int J Hematol       Date:  2008-07-16       Impact factor: 2.490

Review 2.  [Precursors of acute leukemia: myelodysplastic syndromes and myeloproliferative neoplasms].

Authors:  H H Kreipe
Journal:  Pathologe       Date:  2011-11       Impact factor: 1.011

3.  Two CML patients who subsequently developed features of essential thrombocythemia with JAK2-V617F mutation while in complete cytogenetic remission after treatment with imatinib mesylate.

Authors:  Yoo Jin Lee; Joon Ho Moon; Ho Cheol Shin; Jong Won Seo; Seo Ae Han; Sang Kyeong Seo; Sang Kyun Sohn
Journal:  Int J Hematol       Date:  2013-04-24       Impact factor: 2.490

Review 4.  [Chronic myeloid neoplasms. Diagnostic criteria and current therapeutic concepts].

Authors:  A H Schmitt-Graeff
Journal:  Pathologe       Date:  2010-02       Impact factor: 1.011
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.